ODI Pharma AB (publ) (NGM:ODI)
Sweden · Delayed Price · Currency is SEK 3.680
0.00 (0.00%)
At close: Apr 9, 2026
ODI Pharma AB Market Cap
ODI Pharma AB has a market cap or net worth of 67.46 million as of April 10, 2026. Its market cap has increased by 29.22% in one year.
Market Cap
67.46M
Enterprise Value
62.70M
Revenue
20.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.68
Market Cap Chart
Since January 27, 2020, ODI Pharma AB's market cap has decreased from 129.98M to 67.46M, a decrease of -48.10%. That is a compound annual growth rate of -10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 67.46M | -14.81% |
| Dec 30, 2025 | 79.19M | 124.13% |
| Dec 30, 2024 | 35.33M | -53.57% |
| Dec 29, 2023 | 76.10M | 27.88% |
| Dec 30, 2022 | 59.51M | -20.53% |
| Dec 30, 2021 | 74.88M | 1.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coegin Pharma AB | 98.27M |
| Spotlight Group AB | 96.64M |
| Mediacle Group AB | 75.03M |
| GreenMerc AB | 65.01M |
| Suntrade Group AB | 59.87M |
| Katalysen Ventures AB | 58.60M |
| Lohilo Foods AB | 54.62M |
| NGS Group AB | 52.36M |